絞り込み

17791

広告

ELMOD3-SH2D6 gene fusion as a possible co-star actor in autism spectrum disorder scenario.

著者 Loi E , Moi L , Blois S , Bacchelli E , Vega Benedetti AF , Cameli C , Fadda R , Maestrini E , Carta M , Doneddu G , Zavattari P
J Cell Mol Med.2019 Dec 04 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (28view , 0users)

Full Text Sources

Miscellaneous

Autism spectrum disorder (ASD) is a group of neurodevelopmental disorders characterized by high heritability. It is known that genetic factors contribute to ASD pathogenesis. In particular, copy number variants (CNVs) are involved in ASD susceptibility and can affect gene expression regulation. 2p11.2 microdeletions encompassing ELMOD3, CAPG and SH2D6 genes have been described in four unrelated ASD families. The present study revealed that this microdeletion is responsible for the production of a chimeric transcript generated from the fusion between ELMOD3 and SH2D6. The identified transcript showed significantly higher expression levels in subjects carrying the deletion compared to control subjects, suggesting that it is not subjected to nonsense-mediated decay and might encode for a chimeric protein. In conclusion, this study suggests the possible involvement of this gene fusion, together with the other previously identified variants, in ASD.
PMID: 31800155 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード